These findings indicate that inhibition of HIF-2α in aged bones not only results in the reversal of age-related bone loss that has already occurred by restoring osteoblast function but also prevents age-mediated osteoporosis by inhibiting osteoclast differentiation and maturation. Here, EPAS1 is linked to osteoporosis.